Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00233142 · ClinicalTrials.gov registry record · Phase 2
Expressive Writing for Reducing Stress and Diabetic Symptoms in Diabetes Patients
A Phase 2 study, sponsored by Syracuse University.
- Completed
- Registry status
- Phase 2
- Development phase
- 187
- Enrollment target
NCT00233142: Completed Phase 2 study, sponsored by Syracuse University.
NCT00233142 is a Phase 2 study that has completed, run by Syracuse University. The registered enrollment target is 187 participants, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (41% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00233142, a Phase 2 study, has completed, sponsored by Syracuse University.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 187 participants
- Enrollment target
Study Summary
This study will determine whether the psychological benefits of expressive writing extend to diabetic patients, how long the benefits will last, and whether additional expressive writing "booster" sessions will lead to greater and more sustained improvement in diabetes symptoms and well-being.
Interventions
- BEHAVIORAL Expressive writing
- BEHAVIORAL Neutral writing
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 187 participants |
| Start Date | 2005-09 |
| Est. Completion | 2009-02 |
| Phase | Phase 2 |
What the finished NCT00233142 record still lists
NCT00233142 is an interventional study that assigns participants to a tested intervention. The registered 187 participants enrollment target is mid-sized for trials with a published cap, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (41% higher).
The record links to 0 conditions, and to 2 interventions - of which Expressive writing is the first listed.
NCT00233142 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00233142 about?
NCT00233142 is a clinical study titled "Expressive Writing for Reducing Stress and Diabetic Symptoms in Diabetes Patients". This study will determine whether the psychological benefits of expressive writing extend to diabetic patients, how long the benefits will last, and whether additional expressive writing "booster" sessions will lead to greater and more sustained improvement in diabetes symptoms and well-being.
What is the current status of trial NCT00233142?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 187 participants. The study started on 2005-09. Estimated completion is 2009-02.
What interventions are being tested in trial NCT00233142?
The interventions under investigation include: Expressive writing (BEHAVIORAL), Neutral writing (BEHAVIORAL).
Who is sponsoring clinical trial NCT00233142?
This trial is sponsored by Syracuse University, which has 31 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00233142's enrollment target sits among peer trials
187 357th of 2000 higher than 1,644 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06153251 · 187 participants · Phase 1
A Study to Assess BMS-986453 in Participants With Relapsed and/or Refractory Multiple Myeloma
- NCT06254898 · 187 participants · NA
Use of Incentives for Stressful Medical Procedures
- NCT07062237 · 187 participants · NA
A Randomized Clinical Trial Comparing Embryo Euploidy Rates Following Ultrashort Versus Standard Abstinence
- NCT07217574 · 187 participants
Program in Oncology for Tribal Health Systems.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia